← Eichor
Condition: Recurrent Malignant Brain Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Malignant Brain Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Ref
Phase 2 · 1 location(s) · Northwell Health · NCT02800486Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
NA · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07339085Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02754544The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06283927A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) M
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05588141Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid
NA · 1 location(s) · Mayo Clinic · NCT07174661Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Palbociclib and Pembrolizumab In Central Nervous System Metastases
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT02896335Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · 231 location(s) · NRG Oncology · NCT04804644Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
NA · 1 location(s) · Northwell Health · NCT05979064RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Phase 1 · 1 location(s) · University of Florida · NCT06389591LITT Followed by Hypofractionated RT for Recurrent Gliomas
NA · 4 location(s) · University of Maryland, Baltimore · NCT04181684A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Gliobl
Phase 1 · 2 location(s) · University of Florida · NCT04573140Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Phase 1/Phase 2 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT07416188Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Del
Phase 2 · 1 location(s) · The Third Affiliated hospital of Zhejiang Chinese Medical Un · NCT06818331CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT04510051Chronic CED of TPT for Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Jeffrey N. Bruce · NCT06666712Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NA · 8 location(s) · University of California, San Francisco · NCT05057702Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Phase N/A · 8 location(s) · Erasmus Medical Center · NCT06273176HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Phase 1/Phase 2 · 35 location(s) · Children's Oncology Group · NCT04870944Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and
Phase 1 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06914479Sitagliptin in Recurrent/Progressive Grade 4 Glioma
Phase 1 · 1 location(s) · Kailin Yang, MD, PhD · NCT07541781
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.